• Skip to main content
  • Skip to header right navigation
  • Skip to site footer
PALB2 Interest Group

PALB2 Interest Group

  • About
    • PALB2 gene
    • PALB2 mutation and cancer risks
    • A Study of Cancer Risks in PALB2 Mutation Carriers
    • Clinician Info
    • FAQs
  • Team
    • PALB2 Interest Group
    • Our Team
    • Our Collaborators
  • Resources
  • Publications
  • Events
  • Contact Us

ASCO Post – Commentary on the PALB2 ACMG Management Guidelines

12th October 2021

ASCO Post have featured the ACMG PALB2 Management Guidelines with comments from on of the authors, Dr Doug Stewart.

Dr. Stewart is Senior Investigator, Clinical Genetics Branch, Division of Cancer Epidemiology and Genetics, at the National Cancer Institute. He is also a past Chair of the ACMG Professional Practice and Guidelines Committee.

You can read the article here.

Category: News
Previous Post:PALB2 Information session 20th SEP 2021 – recording now available
Next Post:In Memoriam: David Morse Livingston, MD, Renowned Scientist and Discoverer of PALB2

Our Researchers are funded by many organisations including:

European Research Council
Cancer Research UK

Copyright © 2025 · PALB2 Interest Group · All Rights Reserved